美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
70771-1674-9	70771-1674	HUMAN PRESCRIPTION DRUG	Roflumilast	Roflumilast	TABLET	ORAL	20221003	N/A	ANDA	ANDA208303	Zydus Lifesciences Limited	ROFLUMILAST	500 ug/1	90 TABLET in 1 BOTTLE (70771-1674-9)
68382-624-31	68382-624	HUMAN PRESCRIPTION DRUG	Roflumilast	Roflumilast	TABLET	ORAL	20230518	N/A	ANDA	ANDA208303	Zydus Pharmaceuticals USA Inc.	ROFLUMILAST	250 ug/1	1 BLISTER PACK in 1 CARTON (68382-624-31) / 28 TABLET in 1 BLISTER PACK
68382-624-83	68382-624	HUMAN PRESCRIPTION DRUG	Roflumilast	Roflumilast	TABLET	ORAL	20230518	N/A	ANDA	ANDA208303	Zydus Pharmaceuticals USA Inc.	ROFLUMILAST	250 ug/1	2 BLISTER PACK in 1 CARTON (68382-624-83) / 10 TABLET in 1 BLISTER PACK (68382-624-30)
68382-969-06	68382-969	HUMAN PRESCRIPTION DRUG	Roflumilast	Roflumilast	TABLET	ORAL	20221003	N/A	ANDA	ANDA208303	Zydus Pharmaceuticals USA Inc.	ROFLUMILAST	500 ug/1	30 TABLET in 1 BOTTLE (68382-969-06)
68382-969-16	68382-969	HUMAN PRESCRIPTION DRUG	Roflumilast	Roflumilast	TABLET	ORAL	20221003	N/A	ANDA	ANDA208303	Zydus Pharmaceuticals USA Inc.	ROFLUMILAST	500 ug/1	90 TABLET in 1 BOTTLE (68382-969-16)
70771-1674-3	70771-1674	HUMAN PRESCRIPTION DRUG	Roflumilast	Roflumilast	TABLET	ORAL	20221003	N/A	ANDA	ANDA208303	Zydus Lifesciences Limited	ROFLUMILAST	500 ug/1	30 TABLET in 1 BOTTLE (70771-1674-3)
70771-1673-8	70771-1673	HUMAN PRESCRIPTION DRUG	Roflumilast	Roflumilast	TABLET	ORAL	20230518	N/A	ANDA	ANDA208303	Zydus Lifesciences Limited	ROFLUMILAST	250 ug/1	1 BLISTER PACK in 1 CARTON (70771-1673-8) / 28 TABLET in 1 BLISTER PACK
70771-1673-3	70771-1673	HUMAN PRESCRIPTION DRUG	Roflumilast	Roflumilast	TABLET	ORAL	20230518	N/A	ANDA	ANDA208303	Zydus Lifesciences Limited	ROFLUMILAST	250 ug/1	2 BLISTER PACK in 1 CARTON (70771-1673-3) / 10 TABLET in 1 BLISTER PACK (70771-1673-2)